Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37,345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study.
Zhang L, Ye X, Luo S, Xu X, Wang S, Jin K, Zheng Y, Zhu X, Chen D, Jin J, Huang J. Zhang L, et al. Among authors: zhu x. J Cancer Res Clin Oncol. 2023 Jun;149(6):2383-2392. doi: 10.1007/s00432-022-04067-1. Epub 2022 Jun 22. J Cancer Res Clin Oncol. 2023. PMID: 35731275
The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial.
Zhou C, Qiu Y, Wang J, Zhong X, Zhu X, Huang X, Yang L, Ji Q, Zhou F, Wu S, Yang M, Zhang J, Liu K, Ji L, Yang H, Li C, Zhao Y. Zhou C, et al. Among authors: zhu x. Emerg Microbes Infect. 2024 Dec;13(1):2320913. doi: 10.1080/22221751.2024.2320913. Epub 2024 Feb 29. Emerg Microbes Infect. 2024. PMID: 38860446 Clinical Trial.
37,345 results
You have reached the last available page of results. Please see the User Guide for more information.